ENTA - Enanta Pharmaceuticals Inc. (ENTA) CEO Jay Luly on Q4 2020 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA) Q4 2020 Earnings Conference Call November 23, 2020 4:30 PM ET Company Participants Jennifer Viera - Senior Director, IR & Corporate Communications Jay Luly - President, CEO & Director Paul Mellett - SVP, Finance & Administration and CFO Conference Call Participants Roy Buchanan - JMP Securities Yasmeen Rahimi - Piper Sandler Eric Joseph - JP Morgan Jay Olson - Oppenheimer Presentation Operator Good afternoon and welcome to Enanta Pharmaceuticals fiscal fourth quarter and year-end 2020, financial results call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like to turn the call over to Jennifer Viera, Senior Director, Investor Relations. Please go ahead. Jennifer Viera Thank you, operator, and thanks to everyone for joining us this afternoon. The news release
For further details see:
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q4 2020 Results - Earnings Call Transcript